Somanta Pharmaceuticals
Irvine, California, United States
About Somanta Pharmaceuticals
Somanta Pharmaceuticals a development stage biopharmaceutical company, develops drugs primarily for the treatment of cancer. It holds a license to develop Sodium Phenylbutyrate for the treatment of cancer, autoimmune diseases, and other clinical indications. The company's products in the pre-clinical stage of development include Alchemix, which is intended to interrupt various phases of the cancer cell growth cycle by selectively binding to DNA and inhibiting DNA processing enzymes to overcome drug resistant tumors.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.9M
- Last round: Series Unknown (Jan 2006)
- Website: somanta.com
- Phone: +1 949-477-8090
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/somanta-pharmaceuticals-2569082 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.